Shareholders Clear Final Hurdle for United Dogecoin Merger, Approve Name Change to United Compute
SHPH sits 33% above its 52-week low of $2.576.
Summary
Shareholders approved the United Dogecoin merger share issuance, an equity plan increase, and a name change to United Compute Inc. at the September 9 special meeting.
Key Events · Corporate Governance and Compliance · SHPH
-
Merger Share Issuance Approved
Proposal 1 approved issuance of up to ~17.6M shares for the United Dogecoin merger, including Series B-1 conversion, pre-funded warrants, and E.F. Hutton advisory fee shares.
-
Financing Share Issuance Approved
Proposal 2 approved issuance of up to ~5.0M shares for the April 30, 2026 Securities Purchase Agreement, including Series B-2 conversion and warrant exercises.
-
Equity Plan Increase Approved
Proposal 3 increased the 2018 Equity Incentive Plan authorized shares to 8,800,000.
-
Name Change to United Compute Inc.
Proposal 4 approved amending the Certificate of Incorporation to change the company name to United Compute Inc.
Analysis · SHPH · Life Sciences
The September 9 special meeting delivered shareholder approval on all five proposals, clearing the final governance hurdle for the United Dogecoin merger and related financings. The approved issuance of up to approximately 17.6 million shares dwarfs the 1.03 million shares outstanding at the record date, signaling substantial dilution ahead for existing holders. Additionally, the company will be renamed United Compute Inc., marking a strategic pivot. With these approvals in hand, the merger can now proceed to closing.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.5% of the 1993 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SHPH was trading at $3.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2M. The 52-week trading range was $2.58 to $55.90. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.